ResearcherKyushu UniversityActive in the last 2 years

Yuki Mochida

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0003-7484-5380; OpenAlex author ID A5114227820. Sources: OpenAlex.

Their work

Papers: 5
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 30

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 2 papers · 2025: 1 paper · 2026: 1 paper

Papers 5

Cytokine mRNA-based therapy alleviates dendritic cell and T cell paucity to eliminate aggressive pancreatic cancer in preclinical mouse models. Co-author DOI 10.1016/j.ebiom.2026.106137 ↗
Identification of cold tumor induction-related markers in pancreatic cancer and the clinical implication of PCDH7. Co-author DOI 10.1007/s00432-025-06095-z ↗
Combined Autophagy Inhibition and Dendritic Cell Recruitment Induces Antitumor Immunity and Enhances Immune Checkpoint Blockade Sensitivity in Pancreatic Cance… Co-author DOI 10.1158/0008-5472.can-24-0830 ↗
Dynamic glycolytic reprogramming effects on dendritic cells in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s13046-024-03192-8 ↗
Subtypes in pancreatic ductal adenocarcinoma based on niche factor dependency show distinct drug treatment responses. Co-author DOI 10.1186/s13046-022-02301-9 ↗

Closest collaborators

The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Chika Iwamoto · 4 shared papers, 2022–2025 · strength 0.68
- Paper Identification of cold tumor induction-related markers in pancreatic cancer and the clinical implication of PCDH7. DOI 10.1007/s00432-025-06095-z ↗
- Paper Dynamic glycolytic reprogramming effects on dendritic cells in pancreatic ductal adenocarcinoma. DOI 10.1186/s13046-024-03192-8 ↗
- Paper Combined Autophagy Inhibition and Dendritic Cell Recruitment Induces Antitumor Immunity and Enhances Immune Checkpoint … DOI 10.1158/0008-5472.can-24-0830 ↗
Kohei Nakata · 4 shared papers, 2022–2025 · strength 0.68
- Paper Identification of cold tumor induction-related markers in pancreatic cancer and the clinical implication of PCDH7. DOI 10.1007/s00432-025-06095-z ↗
- Paper Dynamic glycolytic reprogramming effects on dendritic cells in pancreatic ductal adenocarcinoma. DOI 10.1186/s13046-024-03192-8 ↗
- Paper Combined Autophagy Inhibition and Dendritic Cell Recruitment Induces Antitumor Immunity and Enhances Immune Checkpoint … DOI 10.1158/0008-5472.can-24-0830 ↗
Kenoki Ohuchida · 4 shared papers, 2022–2025 · strength 0.68
- Paper Identification of cold tumor induction-related markers in pancreatic cancer and the clinical implication of PCDH7. DOI 10.1007/s00432-025-06095-z ↗
- Paper Dynamic glycolytic reprogramming effects on dendritic cells in pancreatic ductal adenocarcinoma. DOI 10.1186/s13046-024-03192-8 ↗
- Paper Combined Autophagy Inhibition and Dendritic Cell Recruitment Induces Antitumor Immunity and Enhances Immune Checkpoint … DOI 10.1158/0008-5472.can-24-0830 ↗
Naoki Ikenaga · 4 shared papers, 2022–2025 · strength 0.68
- Paper Identification of cold tumor induction-related markers in pancreatic cancer and the clinical implication of PCDH7. DOI 10.1007/s00432-025-06095-z ↗
- Paper Dynamic glycolytic reprogramming effects on dendritic cells in pancreatic ductal adenocarcinoma. DOI 10.1186/s13046-024-03192-8 ↗
- Paper Combined Autophagy Inhibition and Dendritic Cell Recruitment Induces Antitumor Immunity and Enhances Immune Checkpoint … DOI 10.1158/0008-5472.can-24-0830 ↗
Chikanori Tsutsumi · 3 shared papers, 2024–2025 · strength 0.55
- Paper Identification of cold tumor induction-related markers in pancreatic cancer and the clinical implication of PCDH7. DOI 10.1007/s00432-025-06095-z ↗
- Paper Dynamic glycolytic reprogramming effects on dendritic cells in pancreatic ductal adenocarcinoma. DOI 10.1186/s13046-024-03192-8 ↗
- Paper Combined Autophagy Inhibition and Dendritic Cell Recruitment Induces Antitumor Immunity and Enhances Immune Checkpoint … DOI 10.1158/0008-5472.can-24-0830 ↗
Koki Oyama · 3 shared papers, 2024–2025 · strength 0.55
- Paper Identification of cold tumor induction-related markers in pancreatic cancer and the clinical implication of PCDH7. DOI 10.1007/s00432-025-06095-z ↗
- Paper Dynamic glycolytic reprogramming effects on dendritic cells in pancreatic ductal adenocarcinoma. DOI 10.1186/s13046-024-03192-8 ↗
- Paper Combined Autophagy Inhibition and Dendritic Cell Recruitment Induces Antitumor Immunity and Enhances Immune Checkpoint … DOI 10.1158/0008-5472.can-24-0830 ↗
Toshiya Abe · 3 shared papers, 2022–2025 · strength 0.50
- Paper Identification of cold tumor induction-related markers in pancreatic cancer and the clinical implication of PCDH7. DOI 10.1007/s00432-025-06095-z ↗
- Paper Combined Autophagy Inhibition and Dendritic Cell Recruitment Induces Antitumor Immunity and Enhances Immune Checkpoint … DOI 10.1158/0008-5472.can-24-0830 ↗
- Paper Subtypes in pancreatic ductal adenocarcinoma based on niche factor dependency show distinct drug treatment responses. DOI 10.1186/s13046-022-02301-9 ↗
Noboru Ideno · 3 shared papers, 2022–2025 · strength 0.50
- Paper Identification of cold tumor induction-related markers in pancreatic cancer and the clinical implication of PCDH7. DOI 10.1007/s00432-025-06095-z ↗
- Paper Combined Autophagy Inhibition and Dendritic Cell Recruitment Induces Antitumor Immunity and Enhances Immune Checkpoint … DOI 10.1158/0008-5472.can-24-0830 ↗
- Paper Subtypes in pancreatic ductal adenocarcinoma based on niche factor dependency show distinct drug treatment responses. DOI 10.1186/s13046-022-02301-9 ↗
Tomohiko Shinkawa · 3 shared papers, 2022–2025 · strength 0.50
- Paper Identification of cold tumor induction-related markers in pancreatic cancer and the clinical implication of PCDH7. DOI 10.1007/s00432-025-06095-z ↗
- Paper Combined Autophagy Inhibition and Dendritic Cell Recruitment Induces Antitumor Immunity and Enhances Immune Checkpoint … DOI 10.1158/0008-5472.can-24-0830 ↗
- Paper Subtypes in pancreatic ductal adenocarcinoma based on niche factor dependency show distinct drug treatment responses. DOI 10.1186/s13046-022-02301-9 ↗
Yoshinao Oda · 3 shared papers, 2022–2024 · strength 0.47
- Paper Dynamic glycolytic reprogramming effects on dendritic cells in pancreatic ductal adenocarcinoma. DOI 10.1186/s13046-024-03192-8 ↗
- Paper Combined Autophagy Inhibition and Dendritic Cell Recruitment Induces Antitumor Immunity and Enhances Immune Checkpoint … DOI 10.1158/0008-5472.can-24-0830 ↗
- Paper Subtypes in pancreatic ductal adenocarcinoma based on niche factor dependency show distinct drug treatment responses. DOI 10.1186/s13046-022-02301-9 ↗
Masafumi Nakamura · 2 shared papers, 2024–2025 · strength 0.39
- Paper Identification of cold tumor induction-related markers in pancreatic cancer and the clinical implication of PCDH7. DOI 10.1007/s00432-025-06095-z ↗
- Paper Dynamic glycolytic reprogramming effects on dendritic cells in pancreatic ductal adenocarcinoma. DOI 10.1186/s13046-024-03192-8 ↗
Koji Shindo · 2 shared papers, 2022–2024 · strength 0.32
- Paper Dynamic glycolytic reprogramming effects on dendritic cells in pancreatic ductal adenocarcinoma. DOI 10.1186/s13046-024-03192-8 ↗
- Paper Subtypes in pancreatic ductal adenocarcinoma based on niche factor dependency show distinct drug treatment responses. DOI 10.1186/s13046-022-02301-9 ↗
Masafumi Nakamura · 2 shared papers, 2022–2024 · strength 0.29
- Paper Combined Autophagy Inhibition and Dendritic Cell Recruitment Induces Antitumor Immunity and Enhances Immune Checkpoint … DOI 10.1158/0008-5472.can-24-0830 ↗
- Paper Subtypes in pancreatic ductal adenocarcinoma based on niche factor dependency show distinct drug treatment responses. DOI 10.1186/s13046-022-02301-9 ↗
Toru Ikegami · 1 shared paper, 2026 · strength 0.22
- Paper Cytokine mRNA-based therapy alleviates dendritic cell and T cell paucity to eliminate aggressive pancreatic cancer in p… DOI 10.1016/j.ebiom.2026.106137 ↗
Daisuke Ban · 1 shared paper, 2026 · strength 0.22
- Paper Cytokine mRNA-based therapy alleviates dendritic cell and T cell paucity to eliminate aggressive pancreatic cancer in p… DOI 10.1016/j.ebiom.2026.106137 ↗
Kentaro Umemura · 1 shared paper, 2026 · strength 0.22
- Paper Cytokine mRNA-based therapy alleviates dendritic cell and T cell paucity to eliminate aggressive pancreatic cancer in p… DOI 10.1016/j.ebiom.2026.106137 ↗
Yosuke Igarashi · 1 shared paper, 2026 · strength 0.22
- Paper Cytokine mRNA-based therapy alleviates dendritic cell and T cell paucity to eliminate aggressive pancreatic cancer in p… DOI 10.1016/j.ebiom.2026.106137 ↗
Yoshiaki Tanji · 1 shared paper, 2026 · strength 0.22
- Paper Cytokine mRNA-based therapy alleviates dendritic cell and T cell paucity to eliminate aggressive pancreatic cancer in p… DOI 10.1016/j.ebiom.2026.106137 ↗
Shinji Tanaka · 1 shared paper, 2026 · strength 0.22
- Paper Cytokine mRNA-based therapy alleviates dendritic cell and T cell paucity to eliminate aggressive pancreatic cancer in p… DOI 10.1016/j.ebiom.2026.106137 ↗
Yoshinao Oda · 1 shared paper, 2025 · strength 0.21
- Paper Identification of cold tumor induction-related markers in pancreatic cancer and the clinical implication of PCDH7. DOI 10.1007/s00432-025-06095-z ↗
Bo Zhang · 1 shared paper, 2024 · strength 0.18
- Paper Dynamic glycolytic reprogramming effects on dendritic cells in pancreatic ductal adenocarcinoma. DOI 10.1186/s13046-024-03192-8 ↗
Nan Sheng · 1 shared paper, 2024 · strength 0.18
- Paper Dynamic glycolytic reprogramming effects on dendritic cells in pancreatic ductal adenocarcinoma. DOI 10.1186/s13046-024-03192-8 ↗
Shuang Fei · 1 shared paper, 2024 · strength 0.18
- Paper Dynamic glycolytic reprogramming effects on dendritic cells in pancreatic ductal adenocarcinoma. DOI 10.1186/s13046-024-03192-8 ↗
Masataka Hayashi · 1 shared paper, 2024 · strength 0.15
- Paper Combined Autophagy Inhibition and Dendritic Cell Recruitment Induces Antitumor Immunity and Enhances Immune Checkpoint … DOI 10.1158/0008-5472.can-24-0830 ↗
Kazuhiro Koikawa · 1 shared paper, 2024 · strength 0.15
- Paper Combined Autophagy Inhibition and Dendritic Cell Recruitment Induces Antitumor Immunity and Enhances Immune Checkpoint … DOI 10.1158/0008-5472.can-24-0830 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.